Latest News
STAT+: Health AI investment: Traits of success and the reckoning
Health AI investment: Traits of success and the reckoning
STAT+: Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial
Eli Lilly’s investigational obesity pill helped lower weight and blood sugar in patients with obesity and type 2 diabetes.
How chatbots talk about suicide
Plus other health news stories of the day from the Morning Rounds newsletter.
Maryland resident is diagnosed with New World screwworm. What to know about the parasite
A person who traveled to El Salvador has been diagnosed with New World screwworm — the first reported U.S. case tied to travel to a country with a cur...
Opinion: Hospice was meant to offer dignity in death — but it fails the most marginalized
Hospice care cannot achieve its mission unless it actively addresses the inequities built into the structures around it.
Opinion: We surveyed hundreds of biomedical researchers about the instability in federal funding. Here’s what they said
“The ship is going down and we are powerless”: What scientists are saying about cuts to federal research funding.
STAT+: Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty
CEO Jacob Thaysen sees Illumina on track to meet his original goal of high single-digit revenue growth by 2027 despite unexpected headwinds.
HHS terminates NIH program aimed at diversifying biomedical workforce
HHS is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the biomedical sciences.
STAT+: Pharmalittle: We’re reading about FDA reporting side effects, pharma plants near disaster zones, and more
The FDA has begun publishing reports of adverse events concerning drugs and biological products on a daily basis
STAT+: AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion
AbbVie said it will buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression, a sign that pharma is warming up more t...
STAT+: Health AI investment: Traits of success and the reckoning
STAT+: Eli Lilly’s obesity pill helped lower weight, blood sugar in key Phase 3 trial
How chatbots talk about suicide
Maryland resident is diagnosed with New World screwworm. What to know about the parasite
Opinion: Hospice was meant to offer dignity in death — but it fails the most marginalized
Opinion: We surveyed hundreds of biomedical researchers about the instability in federal funding. Here’s what they said
STAT+: Illumina CEO sees path to stable growth, even as its academic customers face funding uncertainty
HHS terminates NIH program aimed at diversifying biomedical workforce
STAT+: Pharmalittle: We’re reading about FDA reporting side effects, pharma plants near disaster zones, and more
STAT+: AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago